Skip to main content
Caplight Logo









mimiX Biotherapeutics

mimiX Biotherapeutics

Private
Biel/BienneHealthcare & Life Scienceshttps://www.mimixbio.com/

Last Round

VC Round

Oct 16, 2023

Total Funding Raised

$54,300

Company Overview

mimiX Biotherapeutics is a biotechnology company that develops biofabrication technology using Sound Induced Morphogenesis (SIM) to create patient-specific biological tissue for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, 3D Printing, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biofabricationacoustic biofabricationbioprintingtissue engineeringregenerative medicinedermal substitutelab-grown tissuewound managementpoint-of-caremicrograftssound induced morphogenesisSIMmedical devicebiotech hardwarecellular agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

mimiX Biotherapeutics Comparables

Compare mimiX Biotherapeutics with similar companies based on industry and business-model similarity.

mimiX Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CUTISS AG
81%
Poietis
79%
Brinter
77%

mimiX Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 16, 2023
Convertible DebtAug 25, 2020
GrantApr 7, 2020

Key People

Founding team and executive leadership

Marc Thurner

Chief Executive Officer

Executive Team

mimiX Biotherapeutics Investors

Notable investors and investment history

mimiX Biotherapeutics investors
InvestorRounds
AO FoundationSeed
Venture KickConvertible Debt, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 24, 2026

    Monthly visitors increased 48% MoM.

  • Nov 7, 2025

    Monthly visitors grew 101% MoM.

mimiX Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

mimiX Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about mimiX Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBiel/Bienne
Employee Range7
Year Founded2019
Last FundingOct 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?